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EXPERIENTIA XXI 9 caused by 2.5 mg/kg of chlorpromazine was between 1.9 and 3.1°C. These values are in agreement with the findings of others s,~. AY-9944 produced a maximal decrease of 1.2°C and of 2.8°C at 30 mg/kg and 90 mg/kg dose levels respectively. When both compounds were administered a fall of 6.0 to 7.9°C was recorded. The maximal decrease of temperature was found when AY-9944 was given 5 min before the injection of chlorpromazine. When a dose of 30 mg]kg of AY-9944 was given to mice 30 min before treble the median lethal dose of Schradan (i.e. 50 mg]kg) the agent conferred on the animals some resistance to the anticholinesterase. The mean survival time of mice treated with AY-9944 was 42% longer than that of controls (p < 0.01).
These results suggest that in mice AY-9944 has an inhibitory action on the metabolism of certain drugs. Qualitatively similar results were reported for isoniazid, iproniazid, SKF-525-A when the above three pharmacologic assays were used to estimate inhibition of drug oxidation 8. Hexobarbital sleeping time is regarded as a good index of the activity of microsomal enzymes 10. The enzymes responsible for the metabolism of pentobarbital, hexobarbital, carisoprodol, strychnine and Schradan were only found in microsomes of liver*k It is reasonable to conclude that AY-9944 is also an inhibitor of the 'nonspecific' microsomal oxidase system in the liver.
These results also show that AY-9944 produces hypothermia in mice. Various agents are known which lower body temperature and also potentiate barbiturate hypnosis 8,.2,13. It is evident that the activity of the microsomal oxidase system like that of many other enzyme systems, can be modified by changes in temperature. The questions, however, how the hypothermia and the potentiation of barbiturate hypnosis are related in the case of AY-9944, and what is the underlying mechanism responsible for the hypothermia induced by AY-9944 alone, are to be investigated.
in the treatment of poisoning with organophosphorus anticholinesterases 2-PAM (pyridine-2-aldoxime methiodide) in general is as effective therapeutically as atropine. However, it is reported that 2-PAM treatment is not successful with organophosphorus amides, such as Schradan, which form a very stable complex with the enzyme, acetylcholinesterase ~a. In poisoning with this type of compound, agents will be useful therapeutically only if they have a strong reactivation effect, but AY-9944 may be of use prophylactically because of its inhibitory action on the oxidative conversion of Schradan into a toxic anticholinesterase.
Further studies utilizing biochemical parameters on drug biotransformation are in progress. The study in detail will be published elsewhere. Biol, 6, 55 (1954) ,
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